<DOC>
	<DOCNO>NCT02211560</DOCNO>
	<brief_summary>The primary objective evaluate efficacy safety phosphatidylserine ( PS ) cognitive ability MCI</brief_summary>
	<brief_title>Investigating Phosphatidylserine Based Dietary Approach Management Mild Cognitive Impairment</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>1 . Age great equal 65 less equal 85 year . 2 . Formal education great equal 10 year . 3 . Male female diagnosis Mild Cognitive Impairment ( MCI ) 3 . Male female diagnosis Mild Cognitive Impairment ( MCI ) define Peterson , accord The following : 3.1 Clinical Dementia Rating Scale total score ( CDR ) ≤0.5 , score one six category ( `` box score '' ) ≤ 1 . 3.2 Mini Mental State Exam &gt; 24 3.3 Verbal PairedAssociated Learning test score accord follow age : Ages 6570 less equal 18 Ages 7185* less equal 17 *Eligibility subject age 70 71 ( i.e. , 70.1 ) evaluate accord 7185 age group score . 4 . Adequate vision , hearing , literacy ability allow neuropsychological testing . 5 . Able willing perform study procedure . 6 . Ability provide write consent sign subject 1 . Any significant neurological condition disorder ( e.g. , seizure disorder , epilepsy , brain tumor , stroke , etc . ) could cause cognitive deterioration suspect MCI . 2 . Any medical condition disorder could produce cognitive deterioration ( i.e. , renal , respiratory , cardiac , hepatic disease , diabetes mellitus , endocrine , metabolic hematological disturbance ) unless well control least 3 month . 3 . Clinically significant abnormal serum TSH and/or B12 and/or folic acid level normal range . 4 . History infective inflammatory brain disease include viral , fungal syphilitic etiology . 5 . Head trauma injury immediately precede cognitive deterioration , unless 2 year pass since full cognitive functional recovery . 6 . Depression screen assess Geriatric Depression Scaleshort version ( score ≥5 ) 7 . Current suicidality screen Columbia Suicidality Severity Rating Scale . 8 . Dementia DSMIV criterion . 9 . Concomitant use medication potent psychotropic property ( e.g . antipsychotic , ADHD treatment , lithium carbonate , antiepileptic drug Gabapentin ) . Sedating antihistamine allow administer last dose administer least 12 hour cognitive test . Usage prescription nonprescription antidepressant agent , lipid lower medication , antihypertensive medication stable dosage 2 month prior study entry permit . 10 . Concomitant use medication approve symptomatic treatment dementia due AD ( e.g. , NMDA , acetyl choline esterase inhibitor ) 11 . Use within 3 week prior study entry medication anticholinergic effect ( e.g . Atropine , Scopolamine , Tolterodine , Hyoscyamine , Biperiden , Benzatropine , Trihexyphenidyl , Oxybutynin ) . 12 . Use within 4 week prior study entry dietary supplement contain DHA , EPA , Phosphatidylserine , Phosphatidylcholine ( e.g . Krill oil , Lecithin ) , alphaglycerphosphocholine ( GPC ) . 13 . Use within 4 week prior study entry medical food indicate cognitive memory impairment [ e.g . Axona , Cerefolin , CerefolinNAC , Souvenaid ] . 14 . Concomitant use supplement contain ingredient nootropic vasodilator property ( e.g. , Ginkgo Biloba , Vinpocetine , Piracetam , high energy supplement ) . 15 . Use investigational drug within last 30 day . 16 . Allergic reaction sensitivity marine product ( fish/seafood ) and/or soy . 17 . Any known condition opinion investigator may possibly cause cognitive impairment AD ( mania , alcohol substance abuse , mental retardation , bipolar disorder , panic disorder , obsessive compulsive disorder , posttraumatic stress disorder , psychotic disorder , major psychiatric disorder precede dementia onset affect brain function , major surgery ) and/or limit successful trial completion</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>